BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freise AC, Wu AM. In vivo imaging with antibodies and engineered fragments. Mol Immunol 2015;67:142-52. [PMID: 25934435 DOI: 10.1016/j.molimm.2015.04.001] [Cited by in Crossref: 144] [Cited by in F6Publishing: 155] [Article Influence: 20.6] [Reference Citation Analysis]
Number Citing Articles
1 Fuselli A, de los Milagros Bürgi M, Kratje R, Prieto C. Generation and functional evaluation of novel monoclonal antibodies targeting glycosylated human stem cell factor. Appl Microbiol Biotechnol 2022. [DOI: 10.1007/s00253-022-12282-6] [Reference Citation Analysis]
2 Oroujeni M, Bezverkhniaia EA, Xu T, Liu Y, Plotnikov EV, Karlberg I, Ryer E, Orlova A, Tolmachev V, Frejd FY. Evaluation of an Affibody-Based Binder for Imaging of Immune Check-Point Molecule B7-H3. Pharmaceutics 2022;14:1780. [DOI: 10.3390/pharmaceutics14091780] [Reference Citation Analysis]
3 Slebe M, Pouw JE, Hashemi SM, Menke-van der Houven van Oordt CW, Yaqub MM, Bahce I. Current state and upcoming opportunities for immunoPET biomarkers in lung cancer. Lung Cancer 2022;169:84-93. [DOI: 10.1016/j.lungcan.2022.05.017] [Reference Citation Analysis]
4 Scolaro L, Lorenser D, Quirk BC, Kirk RW, Ho LA, Thomas E, Li J, Saunders CM, Sampson DD, Fuller RO, McLaughlin RA. Multimodal imaging needle combining optical coherence tomography and fluorescence for imaging of live breast cancer cells labeled with a fluorescent analog of tamoxifen. J Biomed Opt 2022;27. [PMID: 35831923 DOI: 10.1117/1.JBO.27.7.076004] [Reference Citation Analysis]
5 Wang Q, Zhang X, Wei W, Cao M. PET Imaging of Lung Cancers in Precision Medicine: Current Landscape and Future Perspective. Mol Pharm 2022. [PMID: 35771950 DOI: 10.1021/acs.molpharmaceut.2c00353] [Reference Citation Analysis]
6 Seifert O, Kontermann RE. GlycoTAIL and FlexiTAIL as Half-Life Extension Modules for Recombinant Antibody Fragments. Molecules 2022;27:3272. [PMID: 35630749 DOI: 10.3390/molecules27103272] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Lumen D, Vugts D, Chomet M, Imlimthan S, Sarparanta M, Vos R, Schreurs M, Verlaan M, Lang PA, Hippeläinen E, Beaino W, Windhorst AD, Airaksinen AJ. Pretargeted PET Imaging with a TCO-Conjugated Anti-CD44v6 Chimeric mAb U36 and [89Zr]Zr-DFO-PEG5-Tz. Bioconjug Chem 2022. [PMID: 35442642 DOI: 10.1021/acs.bioconjchem.2c00164] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Fay R, Törő I, Schinke A, Simic B, Schaefer JV, Dreier B, Plückthun A, Holland JP. Sortase-Mediated Site-Specific Conjugation and 89 Zr-Radiolabeling of Designed Ankyrin Repeat Proteins for PET. Mol Pharmaceutics. [DOI: 10.1021/acs.molpharmaceut.2c00136] [Reference Citation Analysis]
9 Amini A, Safdari Y, Tash Shamsabadi F, Azhdarinia A. Near-Infrared Fluorescence Imaging of EGFR-Overexpressing Tumors in the Mouse Xenograft Model Using scFv-IRDye800CW and Cetuximab-IRDye800CW. Molecular Imaging 2022;2022:1-10. [DOI: 10.1155/2022/9589820] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Comeau ZJ, Lessard BH, Shuhendler AJ. The Need to Pair Molecular Monitoring Devices with Molecular Imaging to Personalize Health. Mol Imaging Biol 2022. [PMID: 35257276 DOI: 10.1007/s11307-022-01714-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Nagornykh AM, Tyumentseva MA, Tyumentsev AI, Akimkin VG. Protocol for chronic hepatitis B virus infection mouse model development by patient-derived orthotopic xenografts. PLoS ONE 2022;17:e0264266. [DOI: 10.1371/journal.pone.0264266] [Reference Citation Analysis]
12 Griffiths GL, Vasquez C, Escorcia F, Clanton J, Lindenberg L, Mena E, Choyke PL. Translating a radiolabeled imaging agent to the clinic. Adv Drug Deliv Rev 2022;181:114086. [PMID: 34942275 DOI: 10.1016/j.addr.2021.114086] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
13 Engudar G, Rodríguez-Rodríguez C, Mishra NK, Bergamo M, Amouroux G, Jensen KJ, Saatchi K, Häfeli UO. Metal-ion coordinated self-assembly of human insulin directs kinetics of insulin release as determined by preclinical SPECT/CT imaging. J Control Release 2022:S0168-3659(22)00046-3. [PMID: 35085699 DOI: 10.1016/j.jconrel.2022.01.032] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Hudson PJ. Antibodies and Improved Engineered Formats (as Reagents). Reference Module in Life Sciences 2022. [DOI: 10.1016/b978-0-12-821618-7.00069-9] [Reference Citation Analysis]
15 Kip A, Heskamp S. Antibodies and antibody constructs as radiopharmaceuticals. Nuclear Medicine and Molecular Imaging 2022. [DOI: 10.1016/b978-0-12-822960-6.00009-0] [Reference Citation Analysis]
16 Alam IS, Shaffer TM, Gambhir SS. Nuclear Imaging of Endogenous Markers of Lymphocyte Response. Nuclear Medicine and Immunology 2022. [DOI: 10.1007/978-3-030-81261-4_2] [Reference Citation Analysis]
17 Ruiz-López E, Calatayud-Pérez J, Castells-Yus I, Gimeno-Peribáñez MJ, Mendoza-Calvo N, Morcillo MÁ, Schuhmacher AJ. Diagnosis of Glioblastoma by Immuno-Positron Emission Tomography. Cancers (Basel) 2021;14:74. [PMID: 35008238 DOI: 10.3390/cancers14010074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
18 Mannar D, Saville JW, Sun Z, Zhu X, Marti MM, Srivastava SS, Berezuk AM, Zhou S, Tuttle KS, Sobolewski MD, Kim A, Treat BR, Da Silva Castanha PM, Jacobs JL, Barratt-boyes SM, Mellors JW, Dimitrov DS, Li W, Subramaniam S. Emerging SARS-CoV-2 Variants of Concern: Spike Protein Mutational Analysis and Epitope for Broad Neutralization.. [DOI: 10.1101/2021.12.17.473178] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
19 Zhang X, Ou C, Liu H, Prabhu SK, Li C, Yang Q, Wang LX. General and Robust Chemoenzymatic Method for Glycan-Mediated Site-Specific Labeling and Conjugation of Antibodies: Facile Synthesis of Homogeneous Antibody-Drug Conjugates. ACS Chem Biol 2021;16:2502-14. [PMID: 34569782 DOI: 10.1021/acschembio.1c00597] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
20 Pedroso CCS, Mann VR, Zuberbühler K, Bohn MF, Yu J, Altoe V, Craik CS, Cohen BE. Immunotargeting of Nanocrystals by SpyCatcher Conjugation of Engineered Antibodies. ACS Nano 2021. [PMID: 34694776 DOI: 10.1021/acsnano.1c07856] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Rijs Z, Jeremiasse B, Shifai N, Gelderblom H, Sier CFM, Vahrmeijer AL, van Leeuwen FWB, van der Steeg AFW, van de Sande MAJ. Introducing Fluorescence-Guided Surgery for Pediatric Ewing, Osteo-, and Rhabdomyosarcomas: A Literature Review. Biomedicines 2021;9:1388. [PMID: 34680505 DOI: 10.3390/biomedicines9101388] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
22 Lü P, Qiu S, Pan Y, Shi S, Yu Q, Yu F, Miao L, Wang H, Chen K. Discovery of an Heparin-Binding Epidermal Growth Factor Domain Antibody from a Phage Library and Analysis of Its Inhibitory Effects in SKOV3 Cells. Cancer Biother Radiopharm 2021. [PMID: 34529926 DOI: 10.1089/cbr.2021.0123] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Kamalinia G, Grindel BJ, Takahashi TT, Millward SW, Roberts RW. Directing evolution of novel ligands by mRNA display. Chem Soc Rev 2021;50:9055-103. [PMID: 34165126 DOI: 10.1039/d1cs00160d] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 12.0] [Reference Citation Analysis]
24 Ruiz-López E, Schuhmacher AJ. Transportation of Single-Domain Antibodies through the Blood-Brain Barrier. Biomolecules 2021;11:1131. [PMID: 34439797 DOI: 10.3390/biom11081131] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
25 Panikar SS, Banu N, Haramati J, Del Toro-Arreola S, Riera Leal A, Salas P. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy. J Control Release 2021;334:389-412. [PMID: 33964364 DOI: 10.1016/j.jconrel.2021.05.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
26 Van Tilbeurgh M, Lemdani K, Beignon AS, Chapon C, Tchitchek N, Cheraitia L, Marcos Lopez E, Pascal Q, Le Grand R, Maisonnasse P, Manet C. Predictive Markers of Immunogenicity and Efficacy for Human Vaccines. Vaccines (Basel) 2021;9:579. [PMID: 34205932 DOI: 10.3390/vaccines9060579] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
27 Peres C, Matos AI, Moura LIF, Acúrcio RC, Carreira B, Pozzi S, Vaskovich-Koubi D, Kleiner R, Satchi-Fainaro R, Florindo HF. Preclinical models and technologies to advance nanovaccine development. Adv Drug Deliv Rev 2021;172:148-82. [PMID: 33711401 DOI: 10.1016/j.addr.2021.03.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 6.0] [Reference Citation Analysis]
28 Lemaitre J, Naninck T, Delache B, Creppy J, Huber P, Holzapfel M, Bouillier C, Contreras V, Martinon F, Kahlaoui N, Pascal Q, Tricot S, Ducancel F, Vecellio L, Le Grand R, Maisonnasse P. Non-human primate models of human respiratory infections. Mol Immunol 2021;135:147-64. [PMID: 33895579 DOI: 10.1016/j.molimm.2021.04.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
29 White JM, Escorcia FE, Viola NT. Perspectives on metals-based radioimmunotherapy (RIT): moving forward. Theranostics 2021;11:6293-314. [PMID: 33995659 DOI: 10.7150/thno.57177] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
30 Herrero Álvarez N, Bauer D, Hernández-Gil J, Lewis JS. Recent Advances in Radiometals for Combined Imaging and Therapy in Cancer. ChemMedChem 2021. [PMID: 33792195 DOI: 10.1002/cmdc.202100135] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 12.0] [Reference Citation Analysis]
31 Fujiwara K, Akiba H, Tsuji AB, Sudo H, Sugyo A, Nagatsu K, Zhang MR, Iwanari H, Kusano-Arai O, Kudo S, Kikuchi C, Tsumoto K, Momose T, Hamakubo T, Higashi T. 64Cu-labeled minibody D2101 visualizes CDH17-positive gastric cancer xenografts with short waiting time. Nucl Med Commun 2020;41:688-95. [PMID: 32371673 DOI: 10.1097/MNM.0000000000001203] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
32 Henneberg S, Hasenberg A, Maurer A, Neumann F, Bornemann L, Gonzalez-Menendez I, Kraus A, Hasenberg M, Thornton CR, Pichler BJ, Gunzer M, Beziere N. Antibody-guided in vivo imaging of Aspergillus fumigatus lung infections during antifungal azole treatment. Nat Commun 2021;12:1707. [PMID: 33731708 DOI: 10.1038/s41467-021-21965-z] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 14.0] [Reference Citation Analysis]
33 González-Gómez R, Pazo-Cid RA, Sarría L, Morcillo MÁ, Schuhmacher AJ. Diagnosis of Pancreatic Ductal Adenocarcinoma by Immuno-Positron Emission Tomography. J Clin Med 2021;10:1151. [PMID: 33801810 DOI: 10.3390/jcm10061151] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
34 Harmand TJ, Islam A, Pishesha N, Ploegh HL. Nanobodies as in vivo, non-invasive, imaging agents. RSC Chem Biol 2021;2:685-701. [PMID: 34212147 DOI: 10.1039/d1cb00023c] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
35 Lwin TM, Hoffman RM, Bouvet M. Unique Benefits of Tumor-Specific Nanobodies for Fluorescence Guided Surgery. Biomolecules 2021;11:311. [PMID: 33670740 DOI: 10.3390/biom11020311] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
36 Li H, Chen Y, Jin Q, Wu Y, Deng C, Gai Y, Sun Z, Li Y, Wang J, Yang Y, Lv Q, Zhang Y, An R, Lan X, Zhang L, Xie M. Noninvasive Radionuclide Molecular Imaging of the CD4-Positive T Lymphocytes in Acute Cardiac Rejection. Mol Pharm 2021;18:1317-26. [PMID: 33506680 DOI: 10.1021/acs.molpharmaceut.0c01155] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
37 Tolmachev V, Orlova A, Sörensen J. The emerging role of radionuclide molecular imaging of HER2 expression in breast cancer. Semin Cancer Biol 2021;72:185-97. [PMID: 33465471 DOI: 10.1016/j.semcancer.2020.10.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 8.0] [Reference Citation Analysis]
38 Arlauckas S, Oh N, Li R, Weissleder R, Miller MA. Macrophage imaging and subset analysis using single-cell RNA sequencing. Nanotheranostics 2021;5:36-56. [PMID: 33391974 DOI: 10.7150/ntno.50185] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
39 Lau J, Lin K, Bénard F. Targeting Carbonic Anhydrase IX in Tumor Imaging and Theranostic Cancer Therapy. Progress in Drug Research 2021. [DOI: 10.1007/978-3-030-79511-5_12] [Reference Citation Analysis]
40 Pratt EC, Tamura R, Grimm J. Cerenkov Imaging. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00028-4] [Reference Citation Analysis]
41 Krasniqi A, Xavier C, Devoogdt N. Newer Bioconjugation Methods. Molecular Imaging 2021. [DOI: 10.1016/b978-0-12-816386-3.00030-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Ferreira VFC, Oliveira BL, D'Onofrio A, Farinha CM, Gano L, Paulo A, Bernardes GJL, Mendes F. In Vivo Pretargeting Based on Cysteine-Selective Antibody Modification with IEDDA Bioorthogonal Handles for Click Chemistry. Bioconjug Chem 2021;32:121-32. [PMID: 33295756 DOI: 10.1021/acs.bioconjchem.0c00551] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
43 Bouleau A, Lebon V, Truillet C. PET imaging of immune checkpoint proteins in oncology. Pharmacol Ther 2021;222:107786. [PMID: 33307142 DOI: 10.1016/j.pharmthera.2020.107786] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
44 Brechbiel MW. Agent Optimization: Absorption, Distribution, Metabolism, Excretion, Dose, and Decay. J Nucl Med 2021;62:455-6. [PMID: 33277392 DOI: 10.2967/jnumed.120.258095] [Reference Citation Analysis]
45 Dmochowska N, Tieu W, Keller MD, Hollis CA, Campaniello MA, Mavrangelos C, Takhar P, Hughes PA. 89Zr-pro-MMP-9 F(ab')2 detects colitis induced intestinal and kidney fibrosis. Sci Rep 2020;10:20372. [PMID: 33230169 DOI: 10.1038/s41598-020-77390-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
46 Altunay B, Morgenroth A, Beheshti M, Vogg A, Wong NCL, Ting HH, Biersack HJ, Stickeler E, Mottaghy FM. HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging. Eur J Nucl Med Mol Imaging 2021;48:1371-89. [PMID: 33179151 DOI: 10.1007/s00259-020-05094-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 12.5] [Reference Citation Analysis]
47 Margarido AS, Bornes L, Vennin C, van Rheenen J. Cellular Plasticity during Metastasis: New Insights Provided by Intravital Microscopy. Cold Spring Harb Perspect Med 2020;10:a037267. [PMID: 31615867 DOI: 10.1101/cshperspect.a037267] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
48 Valeich J, Boyd D, Kanwar M, Stenzel D, De Ghosh D, Ebrahimi A, Woo J, Wang J, Ambrogelly A. Taking the Hinge off: An Approach to Effector-Less Monoclonal Antibodies. Antibodies 2020;9:50. [DOI: 10.3390/antib9040050] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
49 Sivaram AJ, Wardiana A, Preethi SSH, Fuchs AV, Howard CB, Fletcher NL, Bell CA, Thurecht KJ. Effect of Chain-End Chemistries on the Efficiency of Coupling Antibodies to Polymers Using Unnatural Amino Acids. Macromol Rapid Commun 2020;41:e2000294. [PMID: 32935886 DOI: 10.1002/marc.202000294] [Reference Citation Analysis]
50 Scott AM, Akhurst T, Lee FT, Ciprotti M, Davis ID, Weickhardt AJ, Gan HK, Hicks RJ, Lee ST, Kocovski P, Guo N, Oh M, Mileshkin L, Williams S, Murphy D, Pathmaraj K, O'Keefe GJ, Gong SJ, Pedersen JS, Scott FE, Wheatcroft MP, Hudson PJ. First clinical study of a pegylated diabody 124I-labeled PEG-AVP0458 in patients with tumor-associated glycoprotein 72 positive cancers. Theranostics 2020;10:11404-15. [PMID: 33052222 DOI: 10.7150/thno.49422] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
51 Alam IS, Simonetta F, Scheller L, Mayer AT, Murty S, Vermesh O, Nobashi TW, Lohmeyer JK, Hirai T, Baker J, Lau KH, Negrin R, Gambhir SS. Visualization of Activated T Cells by OX40-ImmunoPET as a Strategy for Diagnosis of Acute Graft-versus-Host Disease. Cancer Res 2020;80:4780-90. [PMID: 32900772 DOI: 10.1158/0008-5472.CAN-20-1149] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
52 Li W, Schäfer A, Kulkarni SS, Liu X, Martinez DR, Chen C, Sun Z, Leist SR, Drelich A, Zhang L, Ura ML, Berezuk A, Chittori S, Leopold K, Mannar D, Srivastava SS, Zhu X, Peterson EC, Tseng CT, Mellors JW, Falzarano D, Subramaniam S, Baric RS, Dimitrov DS. High Potency of a Bivalent Human VH Domain in SARS-CoV-2 Animal Models. Cell 2020;183:429-441.e16. [PMID: 32941803 DOI: 10.1016/j.cell.2020.09.007] [Cited by in Crossref: 81] [Cited by in F6Publishing: 84] [Article Influence: 40.5] [Reference Citation Analysis]
53 Yang Y, Liu C, Yang X. Endoscopic Molecular Imaging plus Photoimmunotherapy: A New Strategy for Monitoring and Treatment of Bladder Cancer. Mol Ther Oncolytics 2020;18:409-18. [PMID: 32913890 DOI: 10.1016/j.omto.2020.07.010] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
54 Dewulf J, Adhikari K, Vangestel C, Wyngaert TVD, Elvas F. Development of Antibody Immuno-PET/SPECT Radiopharmaceuticals for Imaging of Oncological Disorders-An Update. Cancers (Basel) 2020;12:E1868. [PMID: 32664521 DOI: 10.3390/cancers12071868] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
55 Guardiola S, Varese M, Taulés M, Díaz-Lobo M, García J, Giralt E. Probing the Kinetic and Thermodynamic Fingerprints of Anti-EGF Nanobodies by Surface Plasmon Resonance. Pharmaceuticals (Basel) 2020;13:E134. [PMID: 32604841 DOI: 10.3390/ph13060134] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Garousi J, Orlova A, Frejd FY, Tolmachev V. Imaging using radiolabelled targeted proteins: radioimmunodetection and beyond. EJNMMI Radiopharm Chem 2020;5:16. [PMID: 32577943 DOI: 10.1186/s41181-020-00094-w] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 11.0] [Reference Citation Analysis]
57 McCarthy CE, White JM, Viola NT, Gibson HM. In vivo Imaging Technologies to Monitor the Immune System. Front Immunol 2020;11:1067. [PMID: 32582173 DOI: 10.3389/fimmu.2020.01067] [Cited by in Crossref: 23] [Cited by in F6Publishing: 27] [Article Influence: 11.5] [Reference Citation Analysis]
58 Ferreira VFC, Correia JDG, Farinha CM, Mendes F. Improved Fmoc-solid-phase peptide synthesis of an extracellular loop of CFTR for antibody selection by the phage display technology. J Pept Sci 2020;26:e3253. [PMID: 32400108 DOI: 10.1002/psc.3253] [Reference Citation Analysis]
59 Iafrate M, Fruhwirth GO. How Non-invasive in vivo Cell Tracking Supports the Development and Translation of Cancer Immunotherapies. Front Physiol 2020;11:154. [PMID: 32327996 DOI: 10.3389/fphys.2020.00154] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 10.0] [Reference Citation Analysis]
60 Wei W, Rosenkrans ZT, Liu J, Huang G, Luo QY, Cai W. ImmunoPET: Concept, Design, and Applications. Chem Rev 2020;120:3787-851. [PMID: 32202104 DOI: 10.1021/acs.chemrev.9b00738] [Cited by in Crossref: 140] [Cited by in F6Publishing: 152] [Article Influence: 70.0] [Reference Citation Analysis]
61 Mcconville P, Lister D. Translational Biomarker Imaging. Biomarkers in Drug Discovery and Development 2020. [DOI: 10.1002/9781119187547.ch29] [Reference Citation Analysis]
62 Xu J, Zhang S, Zhang W, Xie E, Gu M, Wang Y, Yang L, Zhang B, Zhang J, Gu C, Xu T, Li D, Wang F, Huang P, Pan S. SP70-Targeted Imaging for the Early Detection of Lung Adenocarcinoma. Sci Rep 2020;10:2509. [PMID: 32054922 DOI: 10.1038/s41598-020-59439-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
63 Yan H, Ren W, Liu S, Yu Y. Two-photon imaging of aptamer-functionalized Copolymer/TPdye fluorescent organic dots targeted to cancer cells. Anal Chim Acta 2020;1106:199-206. [PMID: 32145849 DOI: 10.1016/j.aca.2020.02.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
64 Eisenblätter M, Wildgruber M. Optical and Optoacoustic Imaging Probes. Molecular Imaging in Oncology 2020. [DOI: 10.1007/978-3-030-42618-7_10] [Reference Citation Analysis]
65 Ahn SH, Iuliano JN, Boros E. Trivalent metal complex geometry of the substrate governs cathepsin B enzymatic cleavage rate. Chem Commun 2020;56:7289-92. [DOI: 10.1039/d0cc02862b] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
66 Debie P, Lafont C, Defrise M, Hansen I, van Willigen DM, van Leeuwen FWB, Gijsbers R, D'Huyvetter M, Devoogdt N, Lahoutte T, Mollard P, Hernot S. Size and affinity kinetics of nanobodies influence targeting and penetration of solid tumours. J Control Release 2020;317:34-42. [PMID: 31734445 DOI: 10.1016/j.jconrel.2019.11.014] [Cited by in Crossref: 78] [Cited by in F6Publishing: 83] [Article Influence: 26.0] [Reference Citation Analysis]
67 Marculescu C, Lakshminarayanan A, Gault J, Knight JC, Folkes LK, Spink T, Robinson CV, Vallis K, Davis BG, Cornelissen B. Probing the limits of Q-tag bioconjugation of antibodies. Chem Commun (Camb) 2019;55:11342-5. [PMID: 31479092 DOI: 10.1039/c9cc02303h] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
68 Dal Corso A, Pignataro L, Belvisi L, Gennari C. Innovative Linker Strategies for Tumor‐Targeted Drug Conjugates. Chem Eur J 2019;25:14740-57. [DOI: 10.1002/chem.201903127] [Cited by in Crossref: 37] [Cited by in F6Publishing: 40] [Article Influence: 12.3] [Reference Citation Analysis]
69 Bobkov V, Arimont M, Zarca A, De Groof TWM, van der Woning B, de Haard H, Smit MJ. Antibodies Targeting Chemokine Receptors CXCR4 and ACKR3. Mol Pharmacol 2019;96:753-64. [PMID: 31481460 DOI: 10.1124/mol.119.116954] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
70 Peltek OO, Muslimov AR, Zyuzin MV, Timin AS. Current outlook on radionuclide delivery systems: from design consideration to translation into clinics. J Nanobiotechnology 2019;17:90. [PMID: 31434562 DOI: 10.1186/s12951-019-0524-9] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 13.7] [Reference Citation Analysis]
71 Lesur O, Chagnon F, Lebel R, Lepage M. In Vivo Endomicroscopy of Lung Injury and Repair in ARDS: Potential Added Value to Current Imaging. J Clin Med 2019;8:E1197. [PMID: 31405200 DOI: 10.3390/jcm8081197] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
72 Olson MT, Ly QP, Mohs AM. Fluorescence Guidance in Surgical Oncology: Challenges, Opportunities, and Translation. Mol Imaging Biol. 2019;21:200-218. [PMID: 29942988 DOI: 10.1007/s11307-018-1239-2] [Cited by in Crossref: 33] [Cited by in F6Publishing: 38] [Article Influence: 11.0] [Reference Citation Analysis]
73 Ulmer N, Ristanovic D, Morbidelli M. Process for Continuous Fab Production by Digestion of IgG. Biotechnol J 2019;14:e1800677. [PMID: 31169346 DOI: 10.1002/biot.201800677] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
74 Zafarnia S, Mrugalla A, Rix A, Doleschel D, Gremse F, Wolf SD, Buyel JF, Albrecht U, Bode JG, Kiessling F, Lederle W. Non-invasive Imaging and Modeling of Liver Regeneration After Partial Hepatectomy. Front Physiol 2019;10:904. [PMID: 31379606 DOI: 10.3389/fphys.2019.00904] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
75 Kristensen LK, Christensen C, Jensen MM, Agnew BJ, Schjöth-Frydendahl C, Kjaer A, Nielsen CH. Site-specifically labeled 89Zr-DFO-trastuzumab improves immuno-reactivity and tumor uptake for immuno-PET in a subcutaneous HER2-positive xenograft mouse model. Theranostics 2019;9:4409-20. [PMID: 31285769 DOI: 10.7150/thno.32883] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 6.7] [Reference Citation Analysis]
76 Bam R, Laffey M, Nottberg K, Lown PS, Hackel BJ, Wilson KE. Affibody-Indocyanine Green Based Contrast Agent for Photoacoustic and Fluorescence Molecular Imaging of B7-H3 Expression in Breast Cancer. Bioconjug Chem 2019;30:1677-89. [PMID: 31082216 DOI: 10.1021/acs.bioconjchem.9b00239] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 7.7] [Reference Citation Analysis]
77 Debie P, Hernot S. Emerging Fluorescent Molecular Tracers to Guide Intra-Operative Surgical Decision-Making. Front Pharmacol 2019;10:510. [PMID: 31139085 DOI: 10.3389/fphar.2019.00510] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 16.7] [Reference Citation Analysis]
78 Bates A, Power CA. David vs. Goliath: The Structure, Function, and Clinical Prospects of Antibody Fragments. Antibodies (Basel) 2019;8:E28. [PMID: 31544834 DOI: 10.3390/antib8020028] [Cited by in Crossref: 82] [Cited by in F6Publishing: 84] [Article Influence: 27.3] [Reference Citation Analysis]
79 Bélanger K, Iqbal U, Tanha J, MacKenzie R, Moreno M, Stanimirovic D. Single-Domain Antibodies as Therapeutic and Imaging Agents for the Treatment of CNS Diseases. Antibodies (Basel) 2019;8:E27. [PMID: 31544833 DOI: 10.3390/antib8020027] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 8.7] [Reference Citation Analysis]
80 Westerlund K, Vorobyeva A, Mitran B, Orlova A, Tolmachev V, Karlström AE, Altai M. Site-specific conjugation of recognition tags to trastuzumab for peptide nucleic acid-mediated radionuclide HER2 pretargeting. Biomaterials 2019;203:73-85. [PMID: 30877838 DOI: 10.1016/j.biomaterials.2019.02.012] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 5.3] [Reference Citation Analysis]
81 Deyev S, Vorobyeva A, Schulga A, Proshkina G, Güler R, Löfblom J, Mitran B, Garousi J, Altai M, Buijs J, Chernov V, Orlova A, Tolmachev V. Comparative Evaluation of Two DARPin Variants: Effect of Affinity, Size, and Label on Tumor Targeting Properties. Mol Pharm 2019;16:995-1008. [PMID: 30608701 DOI: 10.1021/acs.molpharmaceut.8b00922] [Cited by in Crossref: 25] [Cited by in F6Publishing: 28] [Article Influence: 8.3] [Reference Citation Analysis]
82 Schillaci O, Scimeca M, Trivigno D, Chiaravalloti A, Facchetti S, Anemona L, Bonfiglio R, Santeusanio G, Tancredi V, Bonanno E, Urbano N, Mauriello A. Prostate cancer and inflammation: A new molecular imaging challenge in the era of personalized medicine. Nucl Med Biol 2019;68-69:66-79. [PMID: 30770226 DOI: 10.1016/j.nucmedbio.2019.01.003] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 3.7] [Reference Citation Analysis]
83 Kim H, Javed MR, Chen S, Zettlitz KA, Collins J, Wu AM, Kim C“J, Michael van Dam R, Keng PY. On-demand radiosynthesis of N -succinimidyl-4-[ 18 F]fluorobenzoate ([ 18 F]SFB) on an electrowetting-on-dielectric microfluidic chip for 18 F-labeling of protein. RSC Adv 2019;9:32175-83. [DOI: 10.1039/c9ra06158d] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
84 Vugts DJ, van Dongen GAMS. Immunoglobulins as Radiopharmaceutical Vectors. Radiopharmaceutical Chemistry 2019. [DOI: 10.1007/978-3-319-98947-1_9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
85 Punia K, Kronenberg JB, Montclare JK. Protein biomaterials for theranostic applications. Mol Syst Des Eng 2019;4:1074-94. [DOI: 10.1039/c9me00143c] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
86 Smith WJ, Wang G, Gaikwad H, Vu VP, Groman E, Bourne DWA, Simberg D. Accelerated Blood Clearance of Antibodies by Nanosized Click Antidotes. ACS Nano 2018;12:12523-32. [PMID: 30516974 DOI: 10.1021/acsnano.8b07003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
87 Fu R, Carroll L, Yahioglu G, Aboagye EO, Miller PW. Antibody Fragment and Affibody ImmunoPET Imaging Agents: Radiolabelling Strategies and Applications. ChemMedChem 2018;13:2466-78. [PMID: 30246488 DOI: 10.1002/cmdc.201800624] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 12.8] [Reference Citation Analysis]
88 Dmochowska N, Tieu W, Keller MD, Wardill HR, Mavrangelos C, Campaniello MA, Takhar P, Hughes PA. Immuno-PET of Innate Immune Markers CD11b and IL-1β Detects Inflammation in Murine Colitis. J Nucl Med 2019;60:858-63. [PMID: 30413657 DOI: 10.2967/jnumed.118.219287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
89 Morais M, Ma MT. Site-specific chelator-antibody conjugation for PET and SPECT imaging with radiometals. Drug Discov Today Technol 2018;30:91-104. [PMID: 30553525 DOI: 10.1016/j.ddtec.2018.10.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 34] [Article Influence: 8.0] [Reference Citation Analysis]
90 Boogerd LSF, Boonstra MC, Prevoo HAJM, Handgraaf HJM, Kuppen PJK, van de Velde CJH, Fish A, Cordfunke RA, Valentijn ARPM, Terwisscha van Scheltinga AG, MacDonald GC, Cizeau J, Premsukh A, Vinkenburg van Slooten ML, Burggraaf J, Sier CFM, Vahrmeijer AL. Fluorescence-guided tumor detection with a novel anti-EpCAM targeted antibody fragment: Preclinical validation. Surg Oncol. 2019;28:1-8. [PMID: 30851880 DOI: 10.1016/j.suronc.2018.10.004] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
91 Liu X, Wang C, Liu Z. Protein-Engineered Biomaterials for Cancer Theranostics. Adv Healthc Mater 2018;7:e1800913. [PMID: 30260583 DOI: 10.1002/adhm.201800913] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 4.8] [Reference Citation Analysis]
92 Dmochowska N, Wardill HR, Hughes PA. Advances in Imaging Specific Mediators of Inflammatory Bowel Disease. Int J Mol Sci 2018;19:E2471. [PMID: 30134572 DOI: 10.3390/ijms19092471] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 4.0] [Reference Citation Analysis]
93 Odenthal J, Rijpkema M, Bos D, Wagena E, Croes H, Grenman R, Boerman O, Takes R, Friedl P. Targeting CD44v6 for fluorescence-guided surgery in head and neck squamous cell carcinoma. Sci Rep 2018;8:10467. [PMID: 29992954 DOI: 10.1038/s41598-018-28059-9] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
94 Sim D, Song J, Kim J, Lee J, Chung D, Jo K, Kim C, Seo M, Kang HC, Paeng JC, Kim YP, Won H. Enhancing bacterial production of a recombinant cetuximab-Fab by partial humanization and its utility for drug conjugation. Process Biochemistry 2018;69:123-130. [DOI: 10.1016/j.procbio.2018.03.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
95 Ehlerding EB, Ferreira CA, Aluicio-Sarduy E, Jiang D, Lee HJ, Theuer CP, Engle JW, Cai W. 86/90Y-Based Theranostics Targeting Angiogenesis in a Murine Breast Cancer Model. Mol Pharm 2018;15:2606-13. [PMID: 29787283 DOI: 10.1021/acs.molpharmaceut.8b00133] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.8] [Reference Citation Analysis]
96 Kato T, Hasegawa M, Yamamoto T, Miyazaki T, Suzuki R, Wakita T, Suzuki T, Park EY. Expression of a functional intrabody against hepatitis C virus core protein in Escherichia coli and silkworm pupae. Protein Expr Purif 2018;150:61-6. [PMID: 29778543 DOI: 10.1016/j.pep.2018.05.009] [Reference Citation Analysis]
97 Tsai WK, Wu AM. Aligning physics and physiology: Engineering antibodies for radionuclide delivery. J Labelled Comp Radiopharm 2018;61:693-714. [PMID: 29537104 DOI: 10.1002/jlcr.3622] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
98 Alam IS, Mayer AT, Sagiv-Barfi I, Wang K, Vermesh O, Czerwinski DK, Johnson EM, James ML, Levy R, Gambhir SS. Imaging activated T cells predicts response to cancer vaccines. J Clin Invest 2018;128:2569-80. [PMID: 29596062 DOI: 10.1172/JCI98509] [Cited by in Crossref: 78] [Cited by in F6Publishing: 84] [Article Influence: 19.5] [Reference Citation Analysis]
99 Fiedler L, Kellner M, Gosewisch A, Oos R, Böning G, Lindner S, Albert N, Bartenstein P, Reulen H, Zeidler R, Gildehaus F. Evaluation of 177Lu[Lu]-CHX-A″-DTPA-6A10 Fab as a radioimmunotherapy agent targeting carbonic anhydrase XII. Nuclear Medicine and Biology 2018;60:55-62. [DOI: 10.1016/j.nucmedbio.2018.02.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.8] [Reference Citation Analysis]
100 Freise AC, Zettlitz KA, Salazar FB, Lu X, Tavaré R, Wu AM. ImmunoPET Imaging of Murine CD4+ T Cells Using Anti-CD4 Cys-Diabody: Effects of Protein Dose on T Cell Function and Imaging. Mol Imaging Biol 2017;19:599-609. [PMID: 27966069 DOI: 10.1007/s11307-016-1032-z] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
101 Maman S, Witz IP. A history of exploring cancer in context. Nat Rev Cancer 2018;18:359-76. [DOI: 10.1038/s41568-018-0006-7] [Cited by in Crossref: 230] [Cited by in F6Publishing: 242] [Article Influence: 57.5] [Reference Citation Analysis]
102 O'Keefe DS, Bacich DJ, Huang SS, Heston WDW. A Perspective on the Evolving Story of PSMA Biology, PSMA-Based Imaging, and Endoradiotherapeutic Strategies. J Nucl Med 2018;59:1007-13. [PMID: 29674422 DOI: 10.2967/jnumed.117.203877] [Cited by in Crossref: 71] [Cited by in F6Publishing: 81] [Article Influence: 17.8] [Reference Citation Analysis]
103 Warnders FJ, Lub-de Hooge MN, de Vries EGE, Kosterink JGW. Influence of protein properties and protein modification on biodistribution and tumor uptake of anticancer antibodies, antibody derivatives, and non-Ig scaffolds. Med Res Rev 2018;38:1837-73. [PMID: 29635825 DOI: 10.1002/med.21498] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
104 Deonarain MP, Yahioglu G, Stamati I, Pomowski A, Clarke J, Edwards BM, Diez-Posada S, Stewart AC. Small-Format Drug Conjugates: A Viable Alternative to ADCs for Solid Tumours? Antibodies (Basel) 2018;7:E16. [PMID: 31544868 DOI: 10.3390/antib7020016] [Cited by in Crossref: 37] [Cited by in F6Publishing: 38] [Article Influence: 9.3] [Reference Citation Analysis]
105 Duan D, Wang A, Ni L, Zhang L, Yan X, Jiang Y, Mu H, Wu Z, Sun K, Li Y. Trastuzumab- and Fab' fragment-modified curcumin PEG-PLGA nanoparticles: preparation and evaluation in vitro and in vivo. Int J Nanomedicine 2018;13:1831-40. [PMID: 29606874 DOI: 10.2147/IJN.S153795] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 7.0] [Reference Citation Analysis]
106 Maier FC, Schmitt J, Maurer A, Ehrlichmann W, Reischl G, Nikolaou K, Handgretinger R, Pichler BJ, Thaiss WM. Correlation between positron emission tomography and Cerenkov luminescence imaging in vivo and ex vivo using 64Cu-labeled antibodies in a neuroblastoma mouse model. Oncotarget 2016;7:67403-11. [PMID: 27602580 DOI: 10.18632/oncotarget.11795] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
107 Freise AC, Zettlitz KA, Salazar FB, Tavaré R, Tsai WK, Chatziioannou AF, Rozengurt N, Braun J, Wu AM. Immuno-PET in Inflammatory Bowel Disease: Imaging CD4-Positive T Cells in a Murine Model of Colitis. J Nucl Med 2018;59:980-5. [PMID: 29326360 DOI: 10.2967/jnumed.117.199075] [Cited by in Crossref: 39] [Cited by in F6Publishing: 42] [Article Influence: 9.8] [Reference Citation Analysis]
108 Chakravarty R, Rohra N, Chakraborty S, Jain R, Sarma HD, Dash A. Clinically Relevant Radioactive Dose Formulation of 177 Lu-Labeled Cetuximab-Fab Fragment for Potential Use in Cancer Theranostics. ChemistrySelect 2018;3:242-8. [DOI: 10.1002/slct.201702224] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
109 Kikuchi M. Clinical Usefulness of Positron Emission Tomography for Head and Neck Cancer from Current to Near Future. Pract Otol 2018;111:789-802. [DOI: 10.5631/jibirin.111.789] [Reference Citation Analysis]
110 Mendoza G, Ortiz de Solorzano I, Pintre I, Garcia-salinas S, Sebastian V, Andreu V, Gimeno M, Arruebo M. Near infrared dye-labelled polymeric micro- and nanomaterials: in vivo imaging and evaluation of their local persistence. Nanoscale 2018;10:2970-82. [DOI: 10.1039/c7nr07345c] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
111 Garousi J, Lindbo S, Mitran B, Buijs J, Vorobyeva A, Orlova A, Tolmachev V, Hober S. Comparative evaluation of tumor targeting using the anti-HER2 ADAPT scaffold protein labeled at the C-terminus with indium-111 or technetium-99m. Sci Rep 2017;7:14780. [PMID: 29116215 DOI: 10.1038/s41598-017-15366-w] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
112 Tsionou MI, Knapp CE, Foley CA, Munteanu CR, Cakebread A, Imberti C, Eykyn TR, Young JD, Paterson BM, Blower PJ, Ma MT. Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling. RSC Adv 2017;7:49586-99. [PMID: 29308192 DOI: 10.1039/c7ra09076e] [Cited by in Crossref: 90] [Cited by in F6Publishing: 95] [Article Influence: 18.0] [Reference Citation Analysis]
113 Maruthachalam BV, El-sayed A, Liu J, Sutherland AR, Hill W, Alam MK, Pastushok L, Fonge H, Barreto K, Geyer CR. A Single-Framework Synthetic Antibody Library Containing a Combination of Canonical and Variable Complementarity-Determining Regions. ChemBioChem 2017;18:2247-59. [DOI: 10.1002/cbic.201700279] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
114 Lau J, Lin KS, Bénard F. Past, Present, and Future: Development of Theranostic Agents Targeting Carbonic Anhydrase IX. Theranostics 2017;7:4322-39. [PMID: 29158829 DOI: 10.7150/thno.21848] [Cited by in Crossref: 49] [Cited by in F6Publishing: 50] [Article Influence: 9.8] [Reference Citation Analysis]
115 Choi J, Vaidyanathan G, Koumarianou E, Kang CM, Zalutsky MR. Astatine-211 labeled anti-HER2 5F7 single domain antibody fragment conjugates: radiolabeling and preliminary evaluation. Nucl Med Biol 2018;56:10-20. [PMID: 29031230 DOI: 10.1016/j.nucmedbio.2017.09.003] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 8.2] [Reference Citation Analysis]
116 Yun M, Kim DY, Lee JJ, Kim HS, Kim HS, Pyo A, Ryu Y, Kim TY, Zheng JH, Yoo SW, Hyun H, Oh G, Jeong J, Moon M, Min JH, Kwon SY, Kim JY, Chung E, Hong Y, Lee W, Kim HS, Min JJ. A High-Affinity Repebody for Molecular Imaging of EGFR-Expressing Malignant Tumors. Theranostics 2017;7:2620-33. [PMID: 28819451 DOI: 10.7150/thno.18096] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 4.2] [Reference Citation Analysis]
117 Ono M, Watanabe H, Ikehata Y, Ding N, Yoshimura M, Sano K, Saji H. Radioiodination of BODIPY and its application to a nuclear and optical dual functional labeling agent for proteins and peptides. Sci Rep 2017;7:3337. [PMID: 28611426 DOI: 10.1038/s41598-017-03419-z] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
118 Alsaid H, Skedzielewski T, Rambo MV, Hunsinger K, Hoang B, Fieles W, Long ER, Tunstead J, Vugts DJ, Cleveland M, Clarke N, Matheny C, Jucker BM. Non invasive imaging assessment of the biodistribution of GSK2849330, an ADCC and CDC optimized anti HER3 mAb, and its role in tumor macrophage recruitment in human tumor-bearing mice. PLoS One 2017;12:e0176075. [PMID: 28448604 DOI: 10.1371/journal.pone.0176075] [Cited by in Crossref: 20] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
119 Pelaz B, Alexiou C, Alvarez-Puebla RA, Alves F, Andrews AM, Ashraf S, Balogh LP, Ballerini L, Bestetti A, Brendel C, Bosi S, Carril M, Chan WC, Chen C, Chen X, Chen X, Cheng Z, Cui D, Du J, Dullin C, Escudero A, Feliu N, Gao M, George M, Gogotsi Y, Grünweller A, Gu Z, Halas NJ, Hampp N, Hartmann RK, Hersam MC, Hunziker P, Jian J, Jiang X, Jungebluth P, Kadhiresan P, Kataoka K, Khademhosseini A, Kopeček J, Kotov NA, Krug HF, Lee DS, Lehr CM, Leong KW, Liang XJ, Ling Lim M, Liz-Marzán LM, Ma X, Macchiarini P, Meng H, Möhwald H, Mulvaney P, Nel AE, Nie S, Nordlander P, Okano T, Oliveira J, Park TH, Penner RM, Prato M, Puntes V, Rotello VM, Samarakoon A, Schaak RE, Shen Y, Sjöqvist S, Skirtach AG, Soliman MG, Stevens MM, Sung HW, Tang BZ, Tietze R, Udugama BN, VanEpps JS, Weil T, Weiss PS, Willner I, Wu Y, Yang L, Yue Z, Zhang Q, Zhang Q, Zhang XE, Zhao Y, Zhou X, Parak WJ. Diverse Applications of Nanomedicine. ACS Nano 2017;11:2313-81. [PMID: 28290206 DOI: 10.1021/acsnano.6b06040] [Cited by in Crossref: 755] [Cited by in F6Publishing: 776] [Article Influence: 151.0] [Reference Citation Analysis]
120 Kim H, Choi HS, Kim SK, Lee BI, Choi Y. Antigen-responsive molecular sensor enables real-time tumor-specific imaging. Theranostics 2017;7:952-61. [PMID: 28382167 DOI: 10.7150/thno.16647] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.2] [Reference Citation Analysis]
121 Rousseau J, Zhang Z, Dias GM, Zhang C, Colpo N, Bénard F, Lin K. Design, synthesis and evaluation of novel bifunctional tetrahydroxamate chelators for PET imaging of 89 Zr-labeled antibodies. Bioorganic & Medicinal Chemistry Letters 2017;27:708-12. [DOI: 10.1016/j.bmcl.2017.01.052] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
122 Ramamonjisoa N, Ackerstaff E. Characterization of the Tumor Microenvironment and Tumor-Stroma Interaction by Non-invasive Preclinical Imaging. Front Oncol 2017;7:3. [PMID: 28197395 DOI: 10.3389/fonc.2017.00003] [Cited by in Crossref: 58] [Cited by in F6Publishing: 58] [Article Influence: 11.6] [Reference Citation Analysis]
123 Roux A, Gillet R, Huclier-markai S, Ehret-sabatier L, Charbonnière LJ, Nonat AM. Bifunctional bispidine derivatives for copper-64 labelling and positron emission tomography. Org Biomol Chem 2017;15:1475-83. [DOI: 10.1039/c6ob02712a] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
124 Mercier J, Provins L, Hannestad J. Progress and Challenges in the Development of PET Ligands to Aid CNS Drug Discovery. Comprehensive Medicinal Chemistry III 2017. [DOI: 10.1016/b978-0-12-409547-2.12437-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
125 Bailly C, Cléry PF, Faivre-Chauvet A, Bourgeois M, Guérard F, Haddad F, Barbet J, Chérel M, Kraeber-Bodéré F, Carlier T, Bodet-Milin C. Immuno-PET for Clinical Theranostic Approaches. Int J Mol Sci 2016;18:E57. [PMID: 28036044 DOI: 10.3390/ijms18010057] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
126 Adumeau P, Sharma SK, Brent C, Zeglis BM. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 2: Peptide Tags and Unnatural Amino Acids. Mol Imaging Biol 2016;18:153-65. [PMID: 26754791 DOI: 10.1007/s11307-015-0920-y] [Cited by in Crossref: 43] [Cited by in F6Publishing: 47] [Article Influence: 7.2] [Reference Citation Analysis]
127 Lee MTW, Maruani A, Richards DA, Baker JR, Caddick S, Chudasama V. Enabling the controlled assembly of antibody conjugates with a loading of two modules without antibody engineering. Chem Sci 2017;8:2056-60. [PMID: 28451324 DOI: 10.1039/c6sc03655d] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 7.0] [Reference Citation Analysis]
128 Hu LY, Kelly KA, Sutcliffe JL. High-Throughput Approaches to the Development of Molecular Imaging Agents. Mol Imaging Biol 2017;19:163-82. [DOI: 10.1007/s11307-016-1016-z] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
129 Adumeau P, Sharma SK, Brent C, Zeglis BM. Site-Specifically Labeled Immunoconjugates for Molecular Imaging--Part 1: Cysteine Residues and Glycans. Mol Imaging Biol 2016;18:1-17. [PMID: 26754790 DOI: 10.1007/s11307-015-0919-4] [Cited by in Crossref: 72] [Cited by in F6Publishing: 70] [Article Influence: 12.0] [Reference Citation Analysis]
130 Liu C, Zhang X, Song Y, Wang Y, Zhang F, Zhang Y, Zhang Y, Lan X. SPECT and fluorescence imaging of vulnerable atherosclerotic plaque with a vascular cell adhesion molecule 1 single-chain antibody fragment. Atherosclerosis 2016;254:263-70. [PMID: 27680307 DOI: 10.1016/j.atherosclerosis.2016.09.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
131 Keahey P, Ramalingam P, Schmeler K, Richards-Kortum RR. Differential structured illumination microendoscopy for in vivo imaging of molecular contrast agents. Proc Natl Acad Sci U S A 2016;113:10769-73. [PMID: 27621464 DOI: 10.1073/pnas.1613497113] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 3.3] [Reference Citation Analysis]
132 Salema V, López-guajardo A, Gutierrez C, Mencía M, Fernández LÁ. Characterization of nanobodies binding human fibrinogen selected by E. coli display. Journal of Biotechnology 2016;234:58-65. [DOI: 10.1016/j.jbiotec.2016.07.025] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
133 Wang YW, Doerksen JD, Kang S, Walsh D, Yang Q, Hong D, Liu JT. Multiplexed Molecular Imaging of Fresh Tissue Surfaces Enabled by Convection-Enhanced Topical Staining with SERS-Coded Nanoparticles. Small 2016;12:5612-21. [PMID: 27571395 DOI: 10.1002/smll.201601829] [Cited by in Crossref: 41] [Cited by in F6Publishing: 47] [Article Influence: 6.8] [Reference Citation Analysis]
134 Fan X, Guo Y, Wang L, Xiong X, Zhu L, Fang K. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles. Int J Nanomedicine 2016;11:3939-50. [PMID: 27574424 DOI: 10.2147/IJN.S112951] [Cited by in Crossref: 34] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
135 Pandit-Taskar N, O'Donoghue JA, Ruan S, Lyashchenko SK, Carrasquillo JA, Heller G, Martinez DF, Cheal SM, Lewis JS, Fleisher M, Keppler JS, Reiter RE, Wu AM, Weber WA, Scher HI, Larson SM, Morris MJ. First-in-Human Imaging with 89Zr-Df-IAB2M Anti-PSMA Minibody in Patients with Metastatic Prostate Cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. J Nucl Med 2016;57:1858-64. [PMID: 27516450 DOI: 10.2967/jnumed.116.176206] [Cited by in Crossref: 85] [Cited by in F6Publishing: 90] [Article Influence: 14.2] [Reference Citation Analysis]
136 Hettich M, Braun F, Bartholomä MD, Schirmbeck R, Niedermann G. High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers. Theranostics 2016;6:1629-40. [PMID: 27446497 DOI: 10.7150/thno.15253] [Cited by in Crossref: 136] [Cited by in F6Publishing: 148] [Article Influence: 22.7] [Reference Citation Analysis]
137 Massa S, Xavier C, Muyldermans S, Devoogdt N. Emerging site-specific bioconjugation strategies for radioimmunotracer development. Expert Opinion on Drug Delivery 2016;13:1149-63. [DOI: 10.1080/17425247.2016.1178235] [Cited by in Crossref: 33] [Cited by in F6Publishing: 27] [Article Influence: 5.5] [Reference Citation Analysis]
138 Selis F, Focà G, Sandomenico A, Marra C, Di Mauro C, Saccani Jotti G, Scaramuzza S, Politano A, Sanna R, Ruvo M, Tonon G. Pegylated Trastuzumab Fragments Acquire an Increased in Vivo Stability but Show a Largely Reduced Affinity for the Target Antigen. Int J Mol Sci 2016;17:491. [PMID: 27043557 DOI: 10.3390/ijms17040491] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
139 Obonai T, Fuchigami H, Furuya F, Kozuka N, Yasunaga M, Matsumura Y. Tumour imaging by the detection of fibrin clots in tumour stroma using an anti-fibrin Fab fragment. Sci Rep 2016;6:23613. [PMID: 27009516 DOI: 10.1038/srep23613] [Cited by in Crossref: 24] [Cited by in F6Publishing: 24] [Article Influence: 4.0] [Reference Citation Analysis]
140 Ji H, Ingraham CR, Yang X. Molecular imaging: Moving towards infectious diseases. Radiology of Infectious Diseases 2016;3:48-50. [DOI: 10.1016/j.jrid.2016.01.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
141 Fang T, Duarte JN, Ling J, Li Z, Guzman JS, Ploegh HL. Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma. Angew Chem Int Ed Engl 2016;55:2416-20. [PMID: 26840214 DOI: 10.1002/anie.201509432] [Cited by in Crossref: 56] [Cited by in F6Publishing: 61] [Article Influence: 9.3] [Reference Citation Analysis]
142 Fang T, Duarte JN, Ling J, Li Z, Guzman JS, Ploegh HL. Structurally Defined αMHC-II Nanobody-Drug Conjugates: A Therapeutic and Imaging System for B-Cell Lymphoma. Angew Chem 2016;128:2462-6. [DOI: 10.1002/ange.201509432] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
143 Ramsland PA, Hutchinson AT, Carter PJ. Therapeutic antibodies: Discovery, design and deployment. Mol Immunol 2015;67:1-3. [PMID: 25990602 DOI: 10.1016/j.molimm.2015.05.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.1] [Reference Citation Analysis]
144 Kallman M. NMRI Methods in Psychoneuropharmacology. Drug Discovery and Evaluation: Pharmacological Assays 2015. [DOI: 10.1007/978-3-642-27728-3_35-2] [Reference Citation Analysis]